BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10070576)

  • 1. Endobronchial non-Hodgkin's lymphoma.
    McRae WM; Wong CS; Jeffery GM
    Respir Med; 1998 Jul; 92(7):975-7. PubMed ID: 10070576
    [No Abstract]   [Full Text] [Related]  

  • 2. Obstructive solitary bronchial non-Hodgkin's lymphoma--a rare presentation of primary extranodal disease.
    Berkman N; Lafair J; Okon E; Polliack A
    Leuk Lymphoma; 1992 Nov; 8(4-5):405-7. PubMed ID: 1290965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endobronchial non-Hodgkin's lymphoma.
    Ieki R; Goto H; Kouzai Y; Morisaki T; Asano S; Shimada K; Takaku F
    Respir Med; 1989 Jan; 83(1):87-9. PubMed ID: 2479964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in hematological malignancy of aged--therapy of malignant lymphoma in aged].
    Mori M
    Nihon Ronen Igakkai Zasshi; 1992 Mar; 29(3):157-60. PubMed ID: 1375668
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-Hodgkin's lymphoma presenting as an endobronchial tumor: report of eight cases and literature review.
    Solomonov A; Zuckerman T; Goralnik L; Ben-Arieh Y; Rowe JM; Yigla M
    Am J Hematol; 2008 May; 83(5):416-9. PubMed ID: 18175356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy for follicular lymphoma revisited: not if, but when?
    Lister TA
    J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of the indolent non-Hodgkin's lymphomas.
    Portlock CS
    Semin Oncol; 1980 Sep; 7(3):292-301. PubMed ID: 6158100
    [No Abstract]   [Full Text] [Related]  

  • 8. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endobronchial involvement in non-Hodgkin lymphoma.
    Argüder E; Hasanoğlu HC; Karalezli A; Aknc S; Dilek I
    J Bronchology Interv Pulmonol; 2012 Apr; 19(2):142-4. PubMed ID: 23207359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitoxantrone in non-Hodgkin's lymphoma.
    Armitage JO
    Oncology (Williston Park); 2002 Apr; 16(4):490-502, 507-8; discussion 511-2, 514. PubMed ID: 12017536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of non-Hodgkin's lymphoma].
    Schaadt M; Plaumann L; Diehl V
    Dtsch Med Wochenschr; 1984 Feb; 109(7):261-5. PubMed ID: 6199176
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy.
    Choi JH; Choi GB; Shim KN; Sung SH; Han WS; Baek SY
    Acta Haematol; 1997; 97(4):231-5. PubMed ID: 9158668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients].
    González Brito G; Marsá Vilá L; Chávez MI; Batista López N; Hernández Nieto L
    Sangre (Barc); 1985; 30(3):367-8. PubMed ID: 2412301
    [No Abstract]   [Full Text] [Related]  

  • 14. Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
    Babu Rao V; Kerketta L; Madkaikar M; Farah J; Ghosh K
    Acta Haematol; 2006; 116(2):150-2. PubMed ID: 16914914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of primary non-Hodgkin's lymphoma of the vagina with chemotherapy.
    Engin H; Türker A; Abali H; Uner A; Günalp S
    Arch Gynecol Obstet; 2004 Mar; 269(3):208-10. PubMed ID: 12904985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endobronchial High-Grade Non-Hodgkin's Lymphoma.
    Jodra S; Arcos DA; Cordovilla R; Barrueco M
    J Bronchology Interv Pulmonol; 2016 Jul; 23(3):e29-30. PubMed ID: 27454479
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
    Meerwaldt JH; Carde P; Somers R; Thomas J; Kluin-Nelemans JC; Bron D; Noordijk EM; Cosset JM; Bijnens L; Teodorovic I; Hagenbeek A
    Ann Oncol; 1997; 8 Suppl 1():67-70. PubMed ID: 9187434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lactic acidosis in non-Hodgkin's lymphoma].
    Navigante AH; Chacón RD
    Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
    [No Abstract]   [Full Text] [Related]  

  • 20. Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study.
    Van Oers MH; Hagenbeek A; Van Glabbeke M; Teodorovic I
    Ann Hematol; 2002 Oct; 81(10):553-7. PubMed ID: 12424535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.